Case Report: Coadministration of TNF-α blockade as an effective adjunctive strategy in the treatment of ANCA-negative EGPA with refractory peripheral neuropathy
Frontiers in Pharmacology · 09.07.2025 · 16
DOI: 10.3389/fphar.2025.1555377 ↗Kurz gefasst
Fallbericht in der Zeitschrift Frontiers in Pharmacology, online erschienen am 09.07.2025. Verfasst von Dabin Tang und 5 weiteren Autor:innen. Beteiligte Einrichtung: The Department of Rheumatology, The fourth Clinical Medical College of Guangzhou University of Chinese Medicine, Shenzhen, Guangdong, China. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Eosinophilic granulomatosis with polyangiitis (EGPA) is characterized by abnormal eosinophilia and extravascular eosinophilic granuloma formation. Conventional treatments combining glucocorticoids and immunosuppressants can alleviate the condition in most patients with EGPA. However, the efficacy of blocking tumor necrosis factor (TNF)-α-mediated inflammatory reactions in managing EGPA remains controversial. Here, we report a case of refractory EGPA that did not respond to glucocorticoid pulse therapy and adequate cyclophosphamide. The disease was ultimately controlled through the coadministration of etanercept.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The Department of Rheumatology, The fourth Clinical Medical College of Guangzhou University of Chinese Medicine, Shenzhen, Guangdong, China.
- The Department of Rheumatology, Shenzhen Traditional Chinese Medicine Hospital, Shenzhen, Guangdong, China.
Zitieren
APA
Tang, D., Jiang, Y., Yang, S., Wei, J., Xie, J., & Zhang, J. (2025). Case Report: Coadministration of TNF-α blockade as an effective adjunctive strategy in the treatment of ANCA-negative EGPA with refractory peripheral neuropathy. Frontiers in Pharmacology, 16. https://doi.org/10.3389/fphar.2025.1555377
Vancouver
Tang D, Jiang Y, Yang S, Wei J, Xie J, Zhang J. Case Report: Coadministration of TNF-α blockade as an effective adjunctive strategy in the treatment of ANCA-negative EGPA with refractory peripheral neuropathy. Frontiers in Pharmacology. 2025;16. doi:10.3389/fphar.2025.1555377
BibTeX
@article{Tang2025,
author = {Tang, Dabin and Jiang, Yubao and Yang, Shuo and Wei, Jiaxin and Xie, Jingjing and Zhang, Jianyong},
title = {Case Report: Coadministration of TNF-α blockade as an effective adjunctive strategy in the treatment of ANCA-negative EGPA with refractory peripheral neuropathy},
journal = {Frontiers in Pharmacology},
year = {2025},
volume = {16},
doi = {10.3389/fphar.2025.1555377}
}
EUVIMED